Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Phenformin | hsa00030 | Pentose phosphate pathway | 4.23E-02 | 2 | P51854, P37837 | TKTL1, TALDO1 | More | | Phenformin | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Phenformin | hsa00071 | Fatty acid degradation | 2.52E-02 | 3 | O75521, P11766, P33121 | ECI2, ADH5, ACSL1 | More | | Phenformin | hsa00100 | Steroid biosynthesis | 3.94E-02 | 1 | P35610 | SOAT1 | More | | Phenformin | hsa00220 | Arginine biosynthesis | 4.40E-03 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Phenformin | hsa00250 | Alanine, aspartate and glutamate metabolism | 4.40E-03 | 2 | P49448, P15104 | GLUD2, GLUL | More | | Phenformin | hsa00471 | D-Glutamine and D-glutamate metabolism | 3.94E-02 | 1 | P49448 | GLUD2 | More | | Phenformin | hsa00500 | Starch and sucrose metabolism | 3.59E-05 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Phenformin | hsa00562 | Inositol phosphate metabolism | 4.55E-02 | 2 | P27987, P42338 | ITPKB, PIK3CB | More | | Phenformin | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | | Phenformin | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.12E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Phenformin | hsa00730 | Thiamine metabolism | 6.87E-05 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Phenformin | hsa00760 | Nicotinate and nicotinamide metabolism | 3.52E-02 | 1 | P21589 | NT5E | More | | Phenformin | hsa00770 | Pantothenate and CoA biosynthesis | 2.27E-02 | 2 | O95498, O95497 | VNN2, VNN1 | More | | Phenformin | hsa00910 | Nitrogen metabolism | 4.40E-03 | 2 | P15104, P49448 | GLUL, GLUD2 | More | | Phenformin | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.77E-04 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Phenformin | hsa00983 | Drug metabolism - other enzymes | 2.83E-02 | 3 | P20839, P32320, P05164 | IMPDH1, CDA, MPO | More | | Phenformin | hsa01100 | Metabolic pathways | 4.28E-04 | 35 | Q9NR34, P05089, O95455, P21953, P15104, P42338, P27987, P32320, P22748, P11766, P55809, P06280, Q16875, O43286, O43451, P53004, P05186, P24666, Q9HCC0, P33121, Q08477, P09917, P15907, P57054, Q9UNP4, Q9BX95, P37837, P32321, P49448, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737 | MAN1C1, ARG1, TGDS, BCKDHB, GLUL, PIK3CB, ITPKB, CDA, CA4, ADH5, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, BLVRA, ALPL, ACP1, MCCC2, ACSL1, CYP4F3, ALOX5, ST6GAL1, PIGP, ST3GAL5, SGPP1, TALDO1, DCTD, GLUD2, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P05089 | ARG1 | Arginase-1 | 0.807 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O95455 | TGDS | dTDP-D-glucose 4,6-dehydratase | -0.716 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P21953 | BCKDHB | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | 0.765 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P21953 | BCKDHB | 2-oxoisovalerate dehydrogenase subunit beta, mitochondrial | -0.709 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P15104 | GLUL | Glutamine synthetase | -0.819 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.733 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P27987 | ITPKB | Inositol-trisphosphate 3-kinase B | 0.745 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P32320 | CDA | Cytidine deaminase | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P11766 | ADH5 | Alcohol dehydrogenase class-3 | -0.857 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P06280 | GLA | Alpha-galactosidase A | 0.706 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.919 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.779 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | O43451 | MGAM | Maltase-glucoamylase | 0.925 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P53004 | BLVRA | Biliverdin reductase A | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.715 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.71 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.74 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q08477 | CYP4F3 | Cytochrome P450 4F3 | 0.793 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | -0.705 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | -0.722 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | 0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.726 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P37837 | TALDO1 | Transaldolase | 0.843 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P32321 | DCTD | Deoxycytidylate deaminase | 0.79 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P32321 | DCTD | Deoxycytidylate deaminase | -0.737 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P49448 | GLUD2 | Glutamate dehydrogenase 2, mitochondrial | 0.74 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | -0.798 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.899 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.709 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.899 | P51817 | PRKX | cAMP-dependent protein kinase catalytic subunit PRKX | P46976 | GYG1 | Glycogenin-1 | -0.82 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P46976 | GYG1 | Glycogenin-1 | 0.866 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | Q99712 | KCNJ15 | ATP-sensitive inward rectifier potassium channel 15 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.783 |
| Phenformin | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Phenformin | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Phenformin | hsa04060 | Cytokine-cytokine receptor interaction | 4.71E-02 | 2 | P78552, O75509 | IL13RA1, TNFRSF21 | More | | Phenformin | hsa04062 | Chemokine signaling pathway | 2.94E-02 | 4 | P07948, P42338, P50151, P49407 | LYN, PIK3CB, GNG10, ARRB1 | More | | Phenformin | hsa04064 | NF-kappa B signaling pathway | 2.99E-02 | 7 | O00463, P14778, Q13077, Q16548, Q8WV28, P24522, P09341 | TRAF5, IL1R1, TRAF1, BCL2A1, BLNK, GADD45A, CXCL1 | More | | Phenformin | hsa04070 | Phosphatidylinositol signaling system | 1.53E-02 | 2 | Q86XP1, Q96DU7 | DGKH, ITPKC | More | | Phenformin | hsa04071 | Sphingolipid signaling pathway | 2.16E-02 | 5 | P21453, Q9H228, P01375, Q13362, Q9BX95 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1 | More | | Phenformin | hsa04072 | Phospholipase D signaling pathway | 9.70E-03 | 2 | Q92529, Q14344 | SHC3, GNA13 | More | | Phenformin | hsa04080 | Neuroactive ligand-receptor interaction | 2.16E-02 | 7 | P08311, Q15722, P21453, Q9H228, P21462, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, FPR1, C5AR1, ADRB2 | More | | Phenformin | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | | Phenformin | hsa04145 | Phagosome | 2.24E-02 | 6 | O75015, Q15080, P05164, P78380, P35443, P13765 | FCGR3B, NCF4, MPO, OLR1, THBS4, HLA-DOB | More | | Phenformin | hsa04150 | mTOR signaling pathway | 2.23E-02 | 3 | P42338, Q13322, P49841 | PIK3CB, GRB10, GSK3B | More | | Phenformin | hsa04213 | Longevity regulating pathway - multiple species | 2.85E-02 | 2 | Q9Y4H2, Q13547 | IRS2, HDAC1 | More | | Phenformin | hsa04310 | Wnt signaling pathway | 1.79E-02 | 2 | P17612, P67870 | PRKACA, CSNK2B | More | | Phenformin | hsa04340 | Hedgehog signaling pathway | 3.91E-02 | 1 | P17612 | PRKACA | More | | Phenformin | hsa04360 | Axon guidance | 2.19E-02 | 3 | P42338, O14639, P24844 | PIK3CB, ABLIM1, MYL9 | More | | Phenformin | hsa04380 | Osteoclast differentiation | 4.80E-02 | 4 | P06239, P42338, P14778, Q8N149 | LCK, PIK3CB, IL1R1, LILRA2 | More | | Phenformin | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | | Phenformin | hsa04611 | Platelet activation | 2.12E-02 | 2 | Q9Y490, P17612 | TLN1, PRKACA | More | | Phenformin | hsa04612 | Antigen processing and presentation | 5.33E-03 | 7 | P13765, P48382, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Phenformin | hsa04613 | Neutrophil extracellular trap formation | 3.47E-04 | 15 | P11215, P05164, P08246, Q9UM07, Q13547, P58876, Q16778, O60814, Q15080, P20160, P08311, P49913, O75015, P21730, P21462 | ITGAM, MPO, ELA2, PADI4, HDAC1, H2BC5, HIST2H2BE, H2BC12, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, FPR1 | More | | Phenformin | hsa04621 | NOD-like receptor signaling pathway | 1.93E-02 | 8 | Q16539, P10599, Q9H1Y0, P43490, O00463, P01375, P09341, P12838 | MAPK14, TXN, ATG5, PBEF1, TRAF5, TNF, CXCL1, DEFA4 | More | | Phenformin | hsa04640 | Hematopoietic cell lineage | 4.95E-02 | 3 | P01730, P06127, P09564 | CD4, CD5, CD7 | More | | Phenformin | hsa04650 | Natural killer cell mediated cytotoxicity | 4.34E-03 | 8 | P01375, O60880, P20963, Q13241, P26718, O75015, P26717, P26715 | TNF, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KLRC1 | More | | Phenformin | hsa04657 | IL-17 signaling pathway | 2.09E-04 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Phenformin | hsa04658 | Th1 and Th2 cell differentiation | 1.26E-02 | 6 | Q04759, P20963, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, STAT4, GATA3, TBX21, HLA-DOB | More | | Phenformin | hsa04659 | Th17 cell differentiation | 4.12E-02 | 4 | P06239, P14784, P14778, P07766 | LCK, IL2RB, IL1R1, CD3E | More | | Phenformin | hsa04660 | T cell receptor signaling pathway | 5.84E-03 | 8 | P01375, Q04759, P10747, O95267, Q08881, P20963, P01732, Q13191 | TNF, PRKCQ, CD28, RASGRP1, ITK, CD247, CD8A, CBLB | More | | Phenformin | hsa04662 | B cell receptor signaling pathway | 2.37E-04 | 6 | P49841, P42338, P60033, P07948, P21854, Q8N149 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Phenformin | hsa04664 | Fc epsilon RI signaling pathway | 3.97E-03 | 3 | P42338, P07948, P09917 | PIK3CB, LYN, ALOX5 | More | | Phenformin | hsa04727 | GABAergic synapse | 3.63E-02 | 2 | P50151, P15104 | GNG10, GLUL | More | | Phenformin | hsa04730 | Long-term depression | 3.52E-02 | 1 | Q14344 | GNA13 | More | | Phenformin | hsa04742 | Taste transduction | 3.91E-02 | 1 | P17612 | PRKACA | More | | Phenformin | hsa04750 | Inflammatory mediator regulation of TRP channels | 3.72E-02 | 3 | P14778, P42338, P24723 | IL1R1, PIK3CB, PRKCH | More | | Phenformin | hsa04924 | Renin secretion | 1.55E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Phenformin | hsa04926 | Relaxin signaling pathway | 2.59E-02 | 3 | P42338, P50151, P49407 | PIK3CB, GNG10, ARRB1 | More | | Phenformin | hsa04929 | GnRH secretion | 1.13E-03 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Phenformin | hsa04940 | Type I diabetes mellitus | 1.55E-02 | 3 | P10747, P13765, P01375 | CD28, HLA-DOB, TNF | More | | Phenformin | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.38E-02 | 1 | P48048 | KCNJ1 | More | | Phenformin | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Phenformin | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | | Phenformin | hsa04970 | Salivary secretion | 1.74E-02 | 4 | P07550, P22694, Q14643, P49913 | ADRB2, PRKACB, ITPR1, CAMP | More | | Phenformin | hsa04973 | Carbohydrate digestion and absorption | 4.12E-03 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Phenformin | hsa05034 | Alcoholism | 2.10E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Phenformin | hsa05110 | Vibrio cholerae infection | 2.11E-03 | 2 | Q99437, P17612 | ATP6V0B, PRKACA | More | | Phenformin | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.36E-03 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Phenformin | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | | Phenformin | hsa05140 | Leishmaniasis | 1.77E-03 | 7 | P13612, O75015, P13765, O60603, P01375, P49006, Q16539 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MARCKSL1, MAPK14 | More | | Phenformin | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Phenformin | hsa05144 | Malaria | 3.09E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Phenformin | hsa05146 | Amoebiasis | 7.18E-04 | 8 | P09341, P14778, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Phenformin | hsa05150 | Staphylococcus aureus infection | 2.66E-03 | 6 | P21730, P21462, O75015, P13765, P12838, P49913 | C5AR1, FPR1, FCGR3B, HLA-DOB, DEFA4, CAMP | More | | Phenformin | hsa05163 | Human cytomegalovirus infection | 3.44E-03 | 9 | P01375, P50151, Q14643, P49841, P14778, P25025, Q16539, P04637, O00463 | TNF, GNG10, ITPR1, GSK3B, IL1R1, CXCR2, MAPK14, TP53, TRAF5 | More | | Phenformin | hsa05202 | Transcriptional misregulation in cancer | 2.43E-04 | 15 | Q12778, Q13315, P41732, P14780, P27930, Q15744, Q16548, P11215, P35226, P05164, P12838, P08246, Q9C0K0, Q13547, P12980 | FOXO1, ATM, TSPAN7, MMP9, IL1R2, CEBPE, BCL2A1, ITGAM, BMI1, MPO, DEFA4, ELA2, BCL11B, HDAC1, LYL1 | More | | Phenformin | hsa05203 | Viral carcinogenesis | 6.44E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Phenformin | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Phenformin | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Phenformin | hsa05225 | Hepatocellular carcinoma | 1.85E-02 | 2 | Q92529, P51531 | SHC3, SMARCA2 | More | | Phenformin | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.55E-02 | 5 | O95267, P09693, O60603, Q16539, P01730 | RASGRP1, CD3G, TLR2, MAPK14, CD4 | More | | Phenformin | hsa05310 | Asthma | 6.83E-03 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Phenformin | hsa05321 | Inflammatory bowel disease | 2.27E-03 | 5 | P01375, P13765, Q14765, Q9UL17, P23771 | TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Phenformin | hsa05322 | Systemic lupus erythematosus | 3.69E-03 | 9 | O75015, P08246, P08311, P01375, P10747, P13765, P58876, Q16778, O60814 | FCGR3B, ELA2, CTSG, TNF, CD28, HLA-DOB, H2BC5, HIST2H2BE, H2BC12 | More | | Phenformin | hsa05323 | Rheumatoid arthritis | 2.62E-02 | 4 | P01375, P13765, P10747, P09341 | TNF, HLA-DOB, CD28, CXCL1 | More | | Phenformin | hsa05330 | Allograft rejection | 2.83E-02 | 3 | P13765, P10747, P01375 | HLA-DOB, CD28, TNF | More | | Phenformin | hsa05332 | Graft-versus-host disease | 4.66E-04 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Phenformin | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Phenformin | hsa05418 | Fluid shear stress and atherosclerosis | 2.04E-04 | 8 | Q16539, P42338, P10599, P14780, P01375, P04637, P14778, P27930 | MAPK14, PIK3CB, TXN, MMP9, TNF, TP53, IL1R1, IL1R2 | More | | |